Phase I Safety Study of DMXAA in Refractory Tumors

NCT00856336 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Antisoma Research